Ann: 2019 AGM Presentation, page-10

Thoughts from the meeting to answer the questions and statements above. I met a number of the top 20 shareholders.......including the amazing gentlemen AT And Dr H. PYC are a small biotech, the issues are always funding and brokers know this, so sit back. Having AT underwrite 20+m was something purely amazing. PYC have now raised enough money to take their own ( billion USdollar in ann sales) drug thru a phase 2 trial. This drug has a number of issues already solved, and really only the unknown unknowns are in the way. Two other issues will be solved in/by March 2020 if you look at the latest presentation, these results being positive will see a relook at this company by most. As they are targeting a disease with no cure they do not need to do phase III trials, if 2 is successful they can start selling to clients immediately (+ The TGA orphan money at 100m US may well still be on the table as well, as the republicans keep extending) Most international companies in this position have a mcap north of 500m The staff / board are all excited........PYC may have the cure for RP saving the vision of 4000 known people + many others Its not about the money anymore for most staff and investors involved, just the cure!( TRUE!) They have 2 other eye drugs in the pipeline and a DMD type candidate as well later, ie not a one trick pony. And then the platform is also for hire, imagine the attention PYC will get once they pull this off. If you add all this up( as it seems people have been doing over the past 3 months) it means the odds are in PYC's favour and the big boys are taking/ have taken a serious punt. Yes if you want in you now have to pay up, and there are very few for sale.( 500k in fact!) You will need to walk on water to catch the boat. The shares were 6.9c with no path to market. The shares should be higher, looks as if they are going to be soon enough.